Cargando…

Timing of Adjuvant Chemoradiation in pT1-3N1-2 or pT4aN1 Esophageal Squamous Cell Carcinoma After R0 Esophagectomy

INTRODUCTION: Postoperative adjuvant radiation therapy (RT) and chemotherapy (aCRT) have been supposed to improve prognosis and outcomes in patients with node-positive thoracic esophageal squamous cell carcinoma (TESCC). Our aim was to analyze the impacts of interval between surgery and aCRT on prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Leilei, Zhang, Zhenshan, Li, Shuo, Ke, Linping, Yu, Jinming, Meng, Xue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603416/ https://www.ncbi.nlm.nih.gov/pubmed/33149667 http://dx.doi.org/10.2147/CMAR.S276426

Ejemplares similares

Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma
por: Xue, Li-Yan, et al.
Publicado: (2018)

Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy
por: Feng, Wei, et al.
Publicado: (2020)

Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
por: Shin, Hyun Beak, et al.
Publicado: (2017)

Survival risk prediction model for patients with pT(1–3) N(0)M(0) esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes
por: Qi, Zhan, et al.
Publicado: (2021)

YpT1-2N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT1-2N0 rectal cancer
por: Wan, Jue-feng, et al.
Publicado: (2015)

The Impact of Post-Operative Radiotherapy in Early Stage (pT1-pT2N0M0) Oral Tongue Squamous Cell Carcinoma in Era of DOI
por: Alterio, Daniela, et al.
Publicado: (2021)

Close Margins in Oral Cancers: Implication of Close Margin Status in Recurrence and Survival of pT1N0 and pT2N0 Oral Cancers
por: Gokavarapu, Sandhya, et al.
Publicado: (2014)

CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer
por: Zhu, Yingming, et al.
Publicado: (2016)

The Effectiveness of Postoperative Chemotherapy on pT1bN0 and pT2N0 Gastric Cancer Patients with Risk Factors: An International Dual-Center Analysis
por: Yang, Kun, et al.
Publicado: (2021)

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling
por: Xylinas, E, et al.
Publicado: (2012)

Prognostic nomogram and risk factors for predicting survival in patients with pT2N0M0 esophageal squamous carcinoma
por: Kang, Mei, et al.
Publicado: (2023)

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study
por: Gori, Stefania, et al.
Publicado: (2012)

Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2013)

The role of adjuvant therapy in pT4N0 laryngectomized patients: Multicentric observational study
por: Mattioli, Francesco, et al.
Publicado: (2022)

Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+ or pT2–3N0 Gastric Cancer: a Multi-institutional Dataset Analysis
por: Fujita, Keizo, et al.
Publicado: (2020)

Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021)

Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery
por: Peng, Hai-hua, et al.
Publicado: (2019)

Prognostic impact of examined lymph node count in pT1N0M0 esophageal cancer: A population‐based study
por: Liu, Ying, et al.
Publicado: (2019)

Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study
por: Mei, Yu, et al.
Publicado: (2022)

Patterns of Lymph Node Recurrence after Radical Surgery Impacting on Survival of Patients with pT1-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma
por: Chen, Xiao-li, et al.
Publicado: (2014)

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer
por: Gori, Stefania, et al.
Publicado: (2015)

Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer: A single center cohort study
por: Yang, Xuan, et al.
Publicado: (2022)

Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer
por: Akagi, Yoshito, et al.
Publicado: (2013)

In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer
por: Wu, Jun-xin, et al.
Publicado: (2014)

Pattern of recurrence and prognostic factors in patients with pT1-3 N0 esophageal squamous cell carcinoma after surgery: analysis of a single center experience
por: Lin, Gang, et al.
Publicado: (2019)

Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma
por: Liu, Linxiu, et al.
Publicado: (2023)

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer
por: Gori, Stefania, et al.
Publicado: (2015)

The long-term impact of tumor burden in pT3N0M0 esophageal squamous cell carcinoma: A propensity score-matched analysis
por: Li, Tingting, et al.
Publicado: (2019)

Risk Factors and Tumor Recurrence in pT1N0M0 Gastric Cancer after Surgical Treatment
por: Choi, Hee Jun, et al.
Publicado: (2016)

The Impact of Venous Invasion on the Postoperative Recurrence of pT1–3N0cM0 Gastric Cancer
por: Imai, Yasuo, et al.
Publicado: (2023)

Value of N1 Lymph Node Examination in the Prognosis of Patients With pT1-3N0M0 Non-Small Cell Lung Cancer
por: Wang, Gaoxiang, et al.
Publicado: (2020)

Mid- and long-term outcomes of endoscopic resection for submucosal esophageal cancer types pT1b-SM1 and pT1b-SM2
por: Mora, Andres, et al.
Publicado: (2019)

Decision-making of adjuvant therapy in pT1N1M0 gastric cancer: Should radiotherapy be added to chemotherapy? A propensity score-matched analysis
por: Pan, Siwei, et al.
Publicado: (2021)

pT3 N0 Laryngeal Squamous Cell Carcinoma: Oncologic Outcomes and Prognostic Factors of Surgically Treated Patients
por: Mattioli, Francesco, et al.
Publicado: (2021)

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
por: Sato, Yuzuri Tsurumaki, et al.
Publicado: (2014)

Adjuvant chemotherapy guidance for pT1–3N0–1 breast cancer patients with HR(+), HER2(−) subtype: a cohort study based on the SEER database
por: Wen, Nan, et al.
Publicado: (2021)

Outcomes in Patients with pT3N0M0 Breast Cancer with and without Postmastectomy Radiotherapy
por: Li, Chunyan, et al.
Publicado: (2021)

For or against Adjuvant Trastuzumab for pT1a-bN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures
por: Zhou, Qiong, et al.
Publicado: (2014)

Benefits of adjuvant treatment including trastuzumab in HER2-positive pT1a-bN0M0 breast cancer: a systematic review and meta-analysis
por: Lee, Hye Yoon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aqdpqkovmabku60enfgeq016r9